APA (7th ed.) Citation

Yabe, D., Eto, T., Shiramoto, M., Irie, S., Murotani, K., Seino, Y., . . . Seino, Y. (2017). Effects of DPP‐4 inhibitor linagliptin and GLP‐1 receptor agonist liraglutide on physiological response to hypoglycaemia in Japanese subjects with type 2 diabetes: A randomized, open‐label, 2‐arm parallel comparative, exploratory trial. Diabetes, obesity & metabolism, 19(3), 442-447. https://doi.org/10.1111/dom.12817

Chicago Style (17th ed.) Citation

Yabe, Daisuke, et al. "Effects of DPP‐4 Inhibitor Linagliptin and GLP‐1 Receptor Agonist Liraglutide on Physiological Response to Hypoglycaemia in Japanese Subjects with Type 2 Diabetes: A Randomized, Open‐label, 2‐arm Parallel Comparative, Exploratory Trial." Diabetes, Obesity & Metabolism 19, no. 3 (2017): 442-447. https://doi.org/10.1111/dom.12817.

MLA (9th ed.) Citation

Yabe, Daisuke, et al. "Effects of DPP‐4 Inhibitor Linagliptin and GLP‐1 Receptor Agonist Liraglutide on Physiological Response to Hypoglycaemia in Japanese Subjects with Type 2 Diabetes: A Randomized, Open‐label, 2‐arm Parallel Comparative, Exploratory Trial." Diabetes, Obesity & Metabolism, vol. 19, no. 3, 2017, pp. 442-447, https://doi.org/10.1111/dom.12817.